v3.26.1
Segment information - Schedule of asset and income by segment (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Biopharmaceutical [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Interest expense (income)   $ (22,144)   $ (24,727)  
Total operating expenses   4,853,313   8,250,414  
Net (loss) income   (9,834,790)   (18,638,981)  
Total Consolidated [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Interest expense (income)   (90,733)   (157,949)  
Total operating expenses   4,853,439   8,250,862  
Net (loss) income   (9,766,327)   (18,506,208)  
Strategic Investments [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Interest expense (income)   (68,589)   (133,222)  
Total operating expenses   126   448  
Net (loss) income   $ 68,463   $ 132,773  
Reportable segments [member] | Biopharmaceutical [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Current assets $ 9,961,395   $ 9,961,395   $ 6,478,353
Non-current assets 4,430,490   4,430,490   4,682,556
Current liabilities 8,297,670   8,297,670   6,058,294
Interest expense (income) 42,537   52,116    
Total operating expenses 2,293,488   5,259,659    
Net (loss) income (3,092,826)   (16,846,774)    
Reportable segments [member] | Total Consolidated [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Current assets 9,961,395   9,961,395   6,478,353
Non-current assets 4,430,490   4,430,490   4,682,556
Current liabilities 8,297,670   8,297,670   $ 6,058,294
Interest expense (income) 42,544   51,606    
Total operating expenses 2,293,590   5,259,895    
Net (loss) income (3,092,936)   (16,846,500)    
Reportable segments [member] | Strategic Investments [Member]          
Segment information - Schedule of asset and income by segment (Details) [Line Items]          
Interest expense (income) 7   (510)    
Total operating expenses 102   236    
Net (loss) income $ (110)   $ 274